Value added medicines: what value repurposed medicines might bring to society? by Mondher Toumi, Cécile Rémuzat

Get full text

Gene therapies development: slow progress and promising prospect by Eve Hanna, Cécile Rémuzat, Pascal Auquier, Mondher Toumi

Get full text

Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines by Krzysztof Lach, Michal Dziwisz, Cécile Rémuzat, Mondher Toumi

Get full text

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry by Karolina Badora, Aleksandra Caban, Cécile Rémuzat, Claude Dussart, Mondher Toumi

Get full text

Key drivers for market penetration of biosimilars in Europe by Cécile Rémuzat, Julie Dorey, Olivier Cristeau, Dan Ionescu, Guerric Radière, Mondher Toumi

Get full text

Analysis of health economics assessment reports for pharmaceuticals in France – understanding the underlying philosophy of CEESP assessment by Mondher Toumi, Anastasiia Motrunich, Aurélie Millier, Cécile Rémuzat, Christos Chouaid, Bruno Falissard, Samuel Aballéa

Get full text